InvestorsHub Logo
Followers 26
Posts 8986
Boards Moderated 0
Alias Born 12/11/2013

Re: bradfordbros post# 213309

Thursday, 01/18/2018 11:31:32 AM

Thursday, January 18, 2018 11:31:32 AM

Post# of 403747
From Feb 16th 2017, Leo touts CDAs signed... Maybe the data was not good enough to attract a partner from last-year's CDA's so Leo went to SF searching for new prospects? It has to be OM results that failed to impress or we'd see a deal now and Leo would be quiet... P/K are both in trial and UP/Absssi have been frozen...


http://www.ipharminc.com/press-release/2017/2/15/y3616250ilexnq8enkoy8lelciljue

As mentioned by management in previous news releases, a primary focus for the 2017 calendar year is completing work necessary to forge partnerships with larger pharmaceutical companies presently engaged with Cellceutix, some under Confidential Disclosure Agreements (CDAs). Should outcomes from ongoing clinical studies yield favorable results, the Company is optimistic that it will be able to capitalize on the data with respect to a partnership. Securing partnerships would generate substantial shareholder value, while also helping to advance the Company’s innovative drug candidates toward market approval, benefiting patients in need of additional safe and effective treatment options.